Lewis Joel

President And CEO | Director

1 company

Good

Trades Analyzed

12M Win Rate

33.3%

Avg 3M Return

+24.3%

Avg 12M Return

-46.9%

Lewis Joel is a President And CEO at GALECTIN THERAPEUTICS INC. Recent SEC Form 4 filings include 2 buys and 12 sells.

Estimated insider holdings value: $1.7M based on current market prices.

Holdings by Company

GALTJan 6, 2026

Current Shares832.6K

Value$1.75M

Net Activity-197,412

Bought: 4.7KSold: 202.1K

Showing 10 filings

Date	Ticker	Role	Type	Shares	Price	Value	Chg%	3M	12M
Jan 6, 2026	GALT Galectin Therapeutics Inc	President And CEO	Sale+OE	84,000	$3.82	$321,134.30	-3.1%	-25.8%	-
Dec 17, 2025	GALT Galectin Therapeutics Inc	President And CEO	Sale+OE	7,829	$7.06	$55,241.42	-0.9%	-51.3%	-
Nov 18, 2025	GALT Galectin Therapeutics Inc	President And CEO	Sale+OE	22,463	$6.07	$136,365.82	-1.3%	-55.7%	-
Nov 10, 2025	GALT Galectin Therapeutics Inc	President And CEO	Sale+OE	1,867	$6.03	$11,252.22	-0.2%	-47.7%	-
Nov 5, 2025	GALT Galectin Therapeutics Inc	President And CEO	Sale+OE	200	$6.00	$1,200.00	-	-42.3%	-
Nov 4, 2025	GALT Galectin Therapeutics Inc	President And CEO	Sale+OE	15,720	$6.07	$95,342.40	-0.9%	-47.1%	-
Sep 12, 2025	GALT Galectin Therapeutics Inc	President And CEO	Sale+OE	14,000	$6.36	$89,048.40	-1.7%	+6.3%	-
Dec 23, 2024	GALT Galectin Therapeutics Inc	President And CEO	Sale+OE	56,000	$0.89	$49,610.40	-5.9%	+85.4%	+348.3%
Apr 24, 2024	GALT Galectin Therapeutics Inc	President And CEO	Buy	1,000	$3.39	$3,390.00	+100.0%	-21.3%	-56.8%
Feb 16, 2023	GALT Galectin Therapeutics Inc	President And CEO	Buy	1,000	$1.52	$1,520.00	New	+11.3%	+16.0%